Our results reveal that the expression levels of stemness (SOX2, c-MYC, Nanog, and OCT4) and EMT (N-cadherin) markers are positively correlated with the cisplatin resistance development of bladder cancer cells. Here, MYC is linked to urinary bladder carcinoma.